© 2019 Aileron Communications

 

July 13, 2015

After selling his pharmaceutical company, Ovation Pharmaceuticals, in 2009, Marathon Pharmaceuticals CEO Jeff Aronin sat down with the Chicago Tribune to talk exits, startups and orphan drugs.

Entrepreneur Jeff Aronin sold his pharmaceutical company for $900 million in...

January 19, 2015

The Chicago Tribune spoke to families and advocates seeking better treatment options for Duchenne muscular dystrophy as part of their coverage of Marathon Pharmaceuticals, a company working to earn U.S. approval for a Duchenne muscular dystrophy treatment....

Please reload

Search By Tags
Recent Posts
Please reload